Study of CD160, an Activating NK Cell Receptor, in Melanoma: a Potential Therapeutic Target?

Name: Study of CD160, an Activating NK Cell Receptor, in Melanoma: a Potential Therapeutic Target?
License: Public Domain

Assistance Publique - Hôpitaux de Paris

ClinicalTrials.gov · Datasets · License: Public Domain

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 633730
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.